LU501408B1 - A coptis chinensis and atractlodis rhizoma based prescription for treating diabetes - Google Patents

A coptis chinensis and atractlodis rhizoma based prescription for treating diabetes Download PDF

Info

Publication number
LU501408B1
LU501408B1 LU501408A LU501408A LU501408B1 LU 501408 B1 LU501408 B1 LU 501408B1 LU 501408 A LU501408 A LU 501408A LU 501408 A LU501408 A LU 501408A LU 501408 B1 LU501408 B1 LU 501408B1
Authority
LU
Luxembourg
Prior art keywords
stir
fried
rhizoma
atractlodis
coptis chinensis
Prior art date
Application number
LU501408A
Other languages
German (de)
Inventor
Yongxiang Fu
Juanjuan Gu
Fang Zhang
Xiao Li
Yong Yan
Yinshan Wang
Kai Jin
Penghui Li
Original Assignee
Kaifeng Traditional Chinese Medicine Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaifeng Traditional Chinese Medicine Hospital filed Critical Kaifeng Traditional Chinese Medicine Hospital
Priority to LU501408A priority Critical patent/LU501408B1/en
Application granted granted Critical
Publication of LU501408B1 publication Critical patent/LU501408B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/752Citrus, e.g. lime, orange or lemon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/62Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • A61K36/076Poria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284Atractylodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/718Coptis (goldthread)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/72Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
    • A61K36/725Ziziphus, e.g. jujube
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/884Alismataceae (Water-plantain family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9068Zingiber, e.g. garden ginger

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention discloses a Prescription of Coptis Chinensis and Atractlodis Rhizoma prepared with the following raw materials of traditional Chinese medicine: Coptis Chinensis, stir-fried Atractlodis Rhizoma, stir-fried Fructus Aurantii Immaturus, Skunk Bugbane Rhizome, ginger processed Ternate Pinellia, Tangerine Peel, Poria Cocos, Rhizoma Alismatis , Medicated Leaven, Chinese Hawthorn Fruit, Hirudo, Stiff Silkworm, Dried Ginger, Fructus Ziziphi Jujubae and Liquorice Root. Preparation method: mix Coptis Chinensis, stir-fried Atractlodis Rhizoma, stir-fried Fructus Aurantii Immaturus, Skunk Bugbane Rhizome, ginger processed Ternate Pinellia, Tangerine Peel, Poria Cocos, Rhizoma Alismatis , Medicated Leaven, Chinese Hawthorn Fruit, Hirudo, Stiff Silkworm, Dried Ginger, Fructus Ziziphi Jujubae and Liquorice Root and soak with cold water for 30 minutes; add water to 400 ml, boil with strong fire, and then keep boiling for 30 minutes with strong fire, until 150 ml of liquid remains, and pour the remainder out; add water again to 400 ml, boil with strong fire, and then keep boiling with strong fire for about 30 minutes, until 150 ml of liquid remains, and pour the remainder out; mix two decoctions; pulverize the Hirudo; mix the decoction with Hirudo powder before taking. The Prescription of Coptis Chinensis and Atractlodis Rhizoma transports the spleen to clear heat, eliminating turbid blood stasis and mainly treats type 2 diabetes.

Description

BL-5396 1 A COPTIS CHINENSIS AND ATRACTLODIS RHIZOMA BASED LUs01408
PRESCRIPTION FOR TREATING DIABETES TECHNICAL FIELD
[01] The present invention belongs to the technical field of pharmaceutics, and particularly relates to a Coptis Chinensis and Atractlodis Rhizoma based prescription for treating diabetes.
BACKGROUND ART
[02] The stagnation of turbid damp in meridians causes blood stasis, and turbid damp in blood stasis is regarded as be the initiating factor of the change of syndrome of diabetes. The main pathogeneses of diabetes include damage of the spleen and stomach, dysfunction of up-down transportation and transformation, loss of the rest as well as the damp-heat and stasis. The treatment is based on the spleen and stomach of the middle burner, and the legislation is to transport the spleen for clearing heat and eliminating turbid blood stasis.
SUMMARY
[03] The present invention provides a method for treating type 2 diabetes by transporting the spleen to clear heat, eliminating gastrointestinal stasis, and removing blood stasis.
[04] Diabetes mellitus belongs to the category of Xiaoke (diabetes) in traditional Chinese medicine. The term of diabetes was first recorded in Nei Jing (The Internal Canon of Medicine), in which the Su Wen: Qi Bing Pian (Plain Questions-Articles of Odd Diseases) reads: “This person must have eaten a lot of sweets and fats, fats make people a feeling of hotness inside, sweets make people a sense of satiety, therefore their Qi overflows, which is developed into diabetes ” The key pathogenesis of diabetes is proposed: the internal heat, the abdominal distension, caused by eating the high-sugar foods and high-fat foods frequently, delays the development of evil in febrile disease, impedes the turbid dampness, blocks the rising of spleen yang, makes uneven distribution of fluid and qi, resulting in the occurrence of the disease. Subsequently, the Su Wen: Qi Bing Pian (Plain Questions-Articles of Odd Diseases) further proposed the treatment method of "treating the disease with fragrant thoroughwort and removing the stale qi, in which the “fragrant thoroughwort” refers to the fragrant thoroughwort and the “stale qi” refers to the long-term stagnation of qi without being digested. According to the records in the Shen Nong Ben Cao Jing (Sheng Nong's Herbal Classic), the “Fragrant thoroughwort: the taste is pungent and plain; is beneficial for the Shuidao Acupoint; and avoids the ill omen.” It is said that fragrant thoroughwort can be used to remove the stagnation that has not been transformed for a long period of time, 40 indicating that diabetes can be treated by regulating the spleen and stomach, and by using tradition Chinese medicine such as Herba Lycopi and Herba Eupatorii, so as to achieve the effects of removing dampness and activating the spleen, promoting blood circulation and removing blood stasis, thereby making spleen and stomach in the middle burner will be healthy and vigorous, making the qi mechanism smooth, and further
BL-5396 2 eliminating miasma. LUS01408
[05] Based on the above-mentioned contents, the present invention provides a prescription for the treatment of diabetes base on Coptis Chinensis and Atractlodis Rhizoma prepared with the following raw materials of traditional Chinese medicine: Coptis Chinensis 20-40g, stir-fried Atractlodis Rhizoma 8-16g, stir-fried Fructus Aurantii Immaturus 7-13g, Skunk Bugbane Rhizome 7-13g, ginger processed Ternate Pinellia 7-13g, Tangerine Peel 8-16g, Poria Cocos 10-20g, Rhizoma Alismatis 20-40g, stir-fried Medicated Leaven 7-13g, stir-fried Chinese Hawthorn Fruit 20-40g, Hirudo 2-4g, Stiff Silkworm 7-13g, Dried Ginger 7-13g, Fructus Ziziphi Jujubae 7-13g and Liquorice Root 4-8g;
[06] A method for preparing the above prescription for the treatment of diabetes based on Coptis Chinensis and Atractlodis Rhizoma includes the steps of:
[07] S1: mixing Coptis Chinensis, stir-fried Atractlodis Rhizoma, stir-fried Fructus Aurantii Immaturus, Skunk Bugbane Rhizome, ginger processed Ternate Pinellia, Tangerine Peel, Poria Cocos, Rhizoma Alismatis, stir-fried Medicated Leaven, stir-fried Chinese Hawthorn Fruit, Hirudo, Stiff Silkworm, Dried Ginger, Fructus Ziziphi Jujubae and Liquorice Root and soak such raw materials with cold water for 30 minutes.
[08] S2: adding water to 400 ml, boiling the mixture with strong fire, and then keeping the mixture boiling for 30 minutes with strong fire, until 150 ml of liquid remains, and pouring the remainder out.
[09] S3: adding water again to 400 ml, boiling the mixture with strong fire, and then keeping the mixture boiling for 30 minutes with strong fire, until 150 ml of liquid remains, and pouring the remainder out.
[10] S4: mixing two decoctions; pulverizing the Hirudo; mixing the decoction with Hirudo powder before taking.
[11] In the present invention, Coptis Chinensis can diffuse, open up the stagnation, its bitterness nature can dry the dampness, and it coldness nature can prevail heat; stir-fried Rhizoma Atractylodis is pungent and warm in nature, enables both ascending and descending the qi, returns to the spleen and stomach meridians, enlightens the damp-stagnancy of the Triple Burner, replenishes the spleen and upbear the clear, and regulates the middle burner and descends the turbid, which is the monarch drug that play a major role in the main disease or main symptom. Skunk Bugbane Rhizome is clear and flat, and is good at inducing nutrients with warming properties of the middle burner into the heart and lungs, announces the essence of water and grain in the Triple Burner, meridians, and limbs; stir-fried Fructus Aurantii Immaturus has a pungent fragrance, relieves the depression and removes the lump, promotes the flow of the phlegm and the blood stasis in the middle burner, and when the two are mixed, one ascends and one descends, so as to facilitate the transportation and transformation of middle burner. Ginger processed Ternate Pinellia, Tangerine Peel, Poria Cocos and 40 Rhizoma Alismatis promote diuresis, promoting circulation of qi to eliminate phlegm, removing dampness and relieving mass; if the turbid damp stagnates for a long time, the spleen may lose its control and blood stasis may be unfavorable, so stir-fried the Chinese Hawthorn Fruit and the Medicated Leaven are used in order to strengthen the spleen and stomach and promote blood circulation; Hirudo and Stiff Silkworm are salty
BL-5396 3 in taste, Stiff Silkworm reduces phlegm and eliminates stagnation, and Hirudo has a LU501408 great potential to integrate into the blood, so as to attack the long-term stagnation, and the above drugs are all ministerial drug. Dried ginger warms the spleen and prevents the bitterness and the coldness of the Coptis Chinensis, which is considered as an adjuvant drug; Fructus Ziziphi Jujubae invigorates the spleen and replenishes qi, and Liquorice Root tonifies and neutralizes the spleen, which all are envoy drugs. The overall prescription includes the methods of transporting the spleen, diverting stagnation, clearing away heat, ascending the function of the spleen, removing blood stasis, and treating symptoms and root causes, thereby activating the spleen, dispersing the turbid, and eliminating blood stasis, such that the Triple Burner and meridians are unobstructed, and the diabetes is healed naturally.
[12] The present invention has the following advantageous effects:
[13] 1. a Coptis Chinensis and Atractlodis Rhizoma based prescription for treating diabetes of the present invention includes: Coptis Chinensis, stir-fried Atractlodis Rhizoma, stir-fried Fructus Aurantii Immaturus, Skunk Bugbane Rhizome, ginger processed Ternate Pinellia, Tangerine Peel, Poria Cocos, Rhizoma Alismatis , stir-fried Medicated Leaven, stir-fried Chinese Hawthorn Fruit, Hirudo, Stiff Silkworm, Dried Ginger, Fructus Ziziphi Jujubae and Liquorice Root, which are used in combination into a prescription, transporting the spleen to clearing heat, eliminating gastrointestinal stasis and removing blood stasis. The present invention mainly treating type 2 diabetes.
[14] 2. according to clinical observation, the Coptis Chinensis and Atractlodis Rhizoma based prescription for treating diabetes can improve the symptoms and signs of patients, effectively regulate glucose and lipid metabolism disorders, improve insulin resistance, realizes safe medication, stable and reliable efficacy as well as lower costs compared with similar drugs.
[15] 3. clinical application of the Coptis Chinensis and Atractlodis Rhizoma based prescription for treating diabetes of the present invention has excellent effects. A total of 1,128 cases of type 2 diabetes patients were treated, of which 260 cases were cured, 392 cases were markedly effective, 316 cases were clinically effective, with an effective rate of 85.8%.
DETAILED DESCRIPTION OF THE EMBODIMENTS
[16] The following examples are intended to better illustrate the embodiments of the present invention rather than limiting the scope of the invention.
[17] Example 1
[18] A Coptis Chinensis and Atractlodis Rhizoma based prescription for treating diabetes prepared with the following raw materials of traditional Chinese medicine: Coptis Chinensis 21g, stir-fried Atractlodis Rhizoma 9g, stir-fried Fructus Aurantii Immaturus 8g, Skunk Bugbane Rhizome 8g, ginger processed Ternate Pinellia 8g, 40 Tangerine Peel 9g, Poria Cocos 11g, Rhizoma Alismatis 21g, stir-fried Medicated Leaven 8g, stir-fried Chinese Hawthorn Fruit 21g, Hirudo 2g, Stiff Silkworm 8g, Dried Ginger 8g, Fructus Ziziphi Jujubae 8g and Liquorice Root 5g.
[19] Example 2
[20] A Coptis Chinensis and Atractlodis Rhizoma based prescription for treating
BL-5396 4 diabetes prepared with the following raw materials of traditional Chinese medicine: LU501408 Coptis Chinensis 29g, stir-fried Atractlodis Rhizoma 11g, stir-fried Fructus Aurantii Immaturus 9g, Skunk Bugbane Rhizome 9g, ginger processed Ternate Pinellia 9g, Tangerine Peel 11g, Poria Cocos 14g, Rhizoma Alismatis 29g, stir-fried Medicated Leaven 9g, stir-fried Chinese Hawthorn Fruit 29g, Hirudo 3g, Stiff Silkworm 9g, Dried Ginger 9g, Fructus Ziziphi Jujubae 9g and Liquorice Root 6g.
[21] Example 3
[22] A Coptis Chinensis and Atractlodis Rhizoma based prescription for treating diabetes prepared with the following raw materials of traditional Chinese medicine: Coptis Chinensis 31g, stir-fried Atractlodis Rhizoma 13g, stir-fried Fructus Aurantii Immaturus 11g, Skunk Bugbane Rhizome 11g, ginger processed Ternate Pinellia 11g, Tangerine Peel 13g, Poria Cocos 16g, Rhizoma Alismatis 31g, stir-fried Medicated Leaven 11g, stir-fried Chinese Hawthorn Fruit 31g, Hirudo 3g, Stiff Silkworm 11g, Dried Ginger 11g, Fructus Ziziphi Jujubae 11g and Liquorice Root 7g.
[23] Example 4
[24] A Coptis Chinensis and Atractlodis Rhizoma based prescription for treating diabetes prepared with the following raw materials of traditional Chinese medicine: Coptis Chinensis 39g, stir-fried Atractlodis Rhizoma 15g, stir-fried Fructus Aurantii Immaturus 12g, Skunk Bugbane Rhizome 12g, ginger processed Ternate Pinellia 12g, Tangerine Peel 15g, Poria Cocos 19g, Rhizoma Alismatis 39g, stir-fried Medicated Leaven 12g, stir-fried Chinese Hawthorn Fruit 39g, Hirudo 4g, Stiff Silkworm 12g, Dried Ginger 12g, Fructus Ziziphi Jujubae 12g and Liquorice Root 8g.
[25] Example 5
[26] A Coptis Chinensis and Atractlodis Rhizoma based prescription for treating diabetes prepared with the following raw materials of traditional Chinese medicine: Coptis Chinensis 30g, stir-fried Atractlodis Rhizoma 12g, stir-fried Fructus Aurantii Immaturus 10g, Skunk Bugbane Rhizome 10g, ginger processed Ternate Pinellia 10g, Tangerine Peel 12g, Poria Cocos 15g, Rhizoma Alismatis 30g, stir-fried Medicated Leaven 10g, stir-fried Chinese Hawthorn Fruit 30g, Hirudo 3g, Stiff Silkworm 10g, Dried Ginger 10g, Fructus Ziziphi Jujubae 10g and Liquorice Root 6g.
[27] Example 6
[28] A Coptis Chinensis and Atractlodis Rhizoma based prescription for treating diabetes prepared with the following raw materials of traditional Chinese medicine: Coptis Chinensis 20g, stir-fried Atractlodis Rhizoma 8g, stir-fried Fructus Aurantii Immaturus 7g, Skunk Bugbane Rhizome 7g, ginger processed Ternate Pinellia 7g, Tangerine Peel 8g, Poria Cocos 10g, Rhizoma Alismatis 20g, stir-fried Medicated Leaven 7g, stir-fried Chinese Hawthorn Fruit 20g, Hirudo 2g, Stiff Silkworm 7g, Dried Ginger 7g, Fructus Ziziphi Jujubae 7g and Liquorice Root 4g.
[29] Example 7 40 [30] A Coptis Chinensis and Atractlodis Rhizoma based prescription for treating diabetes prepared with the following raw materials of traditional Chinese medicine: Coptis Chinensis 40g, stir-fried Atractlodis Rhizoma 16g, stir-fried Fructus Aurantii Immaturus 13g, Skunk Bugbane Rhizome 13g, ginger processed Ternate Pinellia 13g, Tangerine Peel 16g, Poria Cocos 20g, Rhizoma Alismatis 40g, stir-fried Medicated
BL-5396 5 Leaven 13g, stir-fried Chinese Hawthorn Fruit 40g, Hirudo 4g, Stiff Silkworm 13g, LU501408 Dried Ginger 13g, Fructus Ziziphi Jujubae 13g and Liquorice Root 8g.
[31] Example 8
[32] A method for preparing the Coptis Chinensis and Atractlodis Rhizoma based prescription for treating diabetes in example 5 included the following steps:
[33] S1: Coptis Chinensis 30g, stir-fried Atractlodis Rhizoma 12g, stir-fried Fructus Aurantii Immaturus 10g, Skunk Bugbane Rhizome 10g, ginger processed Ternate Pinellia 10g, Tangerine Peel 12g, Poria Cocos 15g, Rhizoma Alismatis 30g, stir-fried Medicated Leaven 10g, stir-fried Chinese Hawthorn Fruit 30g, Hirudo 3g, Stiff Silkworm 10g, Dried Ginger 10g, Fructus Ziziphi Jujubae 10g and Liquorice Root 6g were mixed and soaked with cold water for 30 minutes.
[34] S2: water was added to 400 ml, the mixture was boiled with strong fire, and then kept boiling for 30 minutes with strong fire, until 150 ml of liquid remains, and the remainder was poured out.
[35] S3: water was added again to 400 ml, the mixture was boiled with strong fire, and then kept boiling for 30 minutes with strong fire, until 150 ml of liquid remains, and the remainder was poured out.
[36] S4: the product was obtained by mixing the liquids after the two decoctions.
[37] Example 9 Clinical application example
[38] The prescription of Coptis Chinensis and Atractlodis Rhizoma is used for the treatment of type 2 diabetes, and has proved excellent efficacy according to clinical trials. Related clinical data are as follows:
[39] 4.1. Comparison of FPG, 2hPG and HbA1C between the two groups prior to and after treatment
[40] The data in Table 1 show no significant difference in FPG 2hPG and HbA1C between the two groups prior to treatment (P> 0.05), FPG 2hPG and HbA1C were significantly different between the two groups before and after treatment (P <0.01); FPG in control group was different (P <0.05), 2hPG and HbA 1C were significantly different; after treatment, FPG had significant difference (P <0.01), 2hPG had significant difference, HbA1C had no significant difference between the two groups.
Table 1 Comparison of FPG 2hPG, HbA1c (mmol/L) between the two groups before and after treatment (x ts ) Pete Tes Item
[41] Note: W denotes no difference between two groups P> 0.05, A denotes difference between two groups P <0.05. A A denotes significant difference between two groups (P <0.01). * denotes the difference between pre-treatment and post-treatment within the same group P <0.05, * * denotes the significant difference between pre-treatment and post-treatment within the same group P <0.01.
[42] 4.2 Comparison of F-ins and HOMA-IR between the two groups before and after treatment
BL-5396 6
[43] The data in Table 2 show no significant difference in pre-treatment F-ins and LU501408 HOMA-IR between the two groups (P> 0.05); there were significant differences in F-ins and HOMA-IR between pre-treatment and post-treatment (P <0.01); there were significant differences in F-ins and HOMA-IR between pre-treatment and post-treatment in control group (P <0.05); there were significant differences in F-ins and HOMA-IR between the two groups after treatment (P <0.01).
[44] Table 2 Comparison of F-ins (uIU/ml), HOMA-IR between the two groups (XE) Pme] Item
[45] Note: V indicates no difference between two groups P> 0.05, A A indicates significant difference between two groups P <0.01. ** indicates significant difference P <0.01 before and after treatment in the same group. * P <0.05 before and after treatment in the same group.
[46] Clinical Application Embodiments of the Coptis Chinensis and Atractlodis Rhizoma based prescription for treating diabetes
[47] Through treatment observation of 1,128 patients, the blood routine, the urine routine, the liver and kidney function, the ECG had no significant changes before and after treatment with the prescription based on Coptis Chinensis and Atractlodis Rhizoma, and no obvious adverse reactions such as allergy occurred. A total of 260 cases were cured, 392 cases were markedly effective, 316 cases were clinically effective, with an effective rate of 85.8%.
[48] The Coptis Chinensis and Atractlodis Rhizoma based prescription for treating diabetes can improve the symptoms and signs of patients, effectively regulate glucose and lipid metabolism disorders, improve insulin resistance, realizes safe medication, stable and reliable efficacy.
[49] Typical Clinical Cases [S0] Typical Case 1
[51] Sun, male, 46 years old. The fasting venous blood glucose of the patient was 9mmol/L according to a physical examination in a local hospital 4 years ago, and the patient was diagnosed as “type 2 diabetes”. No hypoglycemic drugs were taken, but diet and exercise programs were followed to control blood glucose. In the past 4 years, the fasting blood glucose was occasionally measured at 8-9 mmol/L, and the 2-hour postprandial blood glucose was 13 mmol/L. At the time of consultation, symptoms included occasional thirst, polydipsia, bitter mouth, drowsiness of limbs, soreness and weakness of waist and knees, acceptable appetite, acceptable sleep, there was no edema in both lower extremities, defecation was made once a day, and urination is acceptable. The patient also exhibited dark red tongue, thin yellow greasy fur and slippery pulse. After taking the prescription based on Coptis Chinensis and Atractlodis Rhizoma of the present invention for 2 weeks, the symptoms of thirst, polydipsia, bitter mouth, drowsiness of limbs, soreness and weakness of waist and knee were alleviated. After
BL-5396 7 taking the prescription for 2 months, the symptoms of diabetes disappeared, the LU501408 symptoms of bitter mouth, drowsiness of limbs, soreness and weakness of waist and knees were obviously improved, and the mental state was excellent.
[52] Typical Case 2
[53] Zhao, female, 55 years old. The patient was found to have elevated blood glucose according to physical examination (with the specific is unknown) 2 years ago. At that time, there were no symptoms of dry mouth, polydipsia, or polyphagia, and no attention or treatment were given. Later on, symptoms of dry mouth and greasy mouth gradually appeared, and she visited the outpatient department of this hospital. At the time when she went to the clinic, the symptoms were as follows: dry mouth, sticky mouth, decreased appetite, acceptable sleep, normal urination and acceptable defecation, as well as dark tongue, white greasy coating and slippery pulse. After taking the traditional Chinese medicine prescription of the present invention for 1 month, the symptoms of dry mouth and sticky mouth were relieved compared with previous symptoms, and the appetite was acceptable, the urination and defecation were normal, the tongue quality was dull, the tongue coating was white and greasy, and the pulse was thin and slippery. The self-measured fasting blood glucose fluctuated between 6.2 and
7.4 mmol/L, and the 2-hour postprandial blood glucose was 6.8 mmol/L. After taking the traditional Chinese medicine prescription of the present invention for 3 months, the patient had no complaints of special discomforts, the urination was normal, the defecation was slightly dry, the tongue was in dark red color, the tongue coating was thin and white, and the pulse was deep and slippery. Blood glucose control was stable, and pancreatic islet functions were significantly improved.
[54] Typical Case 3 [SS] Feng, male, 60 years old. The patient was found high blood glucose at 16.86 mmol/L during the physical examination at the First People's Hospital of Lankao County on June 22, 2018, accompanied by thirst, polydipsia, polyuria without significant weight loss. The patient was diagnosed as “type 2 diabetes” and then was administered “metformin sustained-release tablets 1.0g bid po, acarbose 50mg tid po” to control blood glucose. On July 4, 2018, according to the reexamination results, the fasting blood glucose was 6.13 mmol/L, the glycosylated hemoglobin level was 8.2%, and symptoms of dry mouth and thirst, polydipsia and polyuria symptoms were not improved significantly. When he visited to the clinic, the symptoms were as follows: the patient had clear mind, acceptable spirit, dry and thirsty mouth, polydipsia, fatigue and drowsiness, soreness of waist and knees, acceptable appetite, acceptable sleep, defecation once a day and frequent urination. Two months after taking the traditional Chinese medicine prescription of the present invention, symptoms of dry and thirsty mouth as well as polydipsia were improved than previous symptoms, the fatigue and drowsiness disappeared, and the soreness of waist and knees were improved than 40 previous symptoms. Blood glucose was 7.6 mmol/L measured 2-hours after lunch on the previous day, 7.3 mmol/L prior to dinner, the fasting blood glucose was 6.4 mmol/L on this morning and 7.6 mmol/L measured 2 hours after breakfast.

Claims (4)

BL-5396 8 CLAIMS LU501408
1. A Coptis Chinensis and Atractlodis Rhizoma based prescription for treating diabetes, wherein the prescription is prepared with the following raw materials of traditional Chinese medicine: Coptis Chinensis 15-39g, stir-fried Atractlodis Rhizoma 10-15g, stir-fried Fructus Aurantii Immaturus 10-12g, Skunk Bugbane Rhizome 6-12g, ginger processed Ternate Pinellia 10-12g, Tangerine Peel 6-12g, Poria Cocos 16-19g, Rhizoma Alismatis 15-30g, stir-fried Medicated Leaven 10-12g, stir-fried Chinese Hawthorn Fruit 10-30g, Hirudo 3-4g, Stiff Silkworm 10-12g, Dried Ginger 6-12g, Fructus Ziziphi Jujubae 6-12g and Liquorice Root 6-8g; the Coptis Chinensis and Atractlodis Rhizoma based prescription for treating diabetes is prepared by the following steps: S1: mixing Coptis Chinensis, stir-fried Atractlodis Rhizoma, stir-fried Fructus Aurantii Immaturus, Skunk Bugbane Rhizome, ginger processed Ternate Pinellia, Tangerine Peel, Poria Cocos, Rhizoma Alismatis, Medicated Leaven, Chinese Hawthorn Fruit, Hirudo, Stiff Silkworm, Dried Ginger, Fructus Ziziphi Jujubae and Liquorice Root and soaking such raw materials with cold water for 30 minutes; S2: adding water to 400 ml, boiling the mixture with strong fire, and then keeping the mixture boiling for 30 minutes with strong fire, until 150 ml of liquid remains, and pouring the remainder out; S3: adding water again to 400 ml, boiling the mixture with strong fire, and then keep the mixture boiling for 30 minutes with strong fire, until 150 ml of liquid remains, and pouring the remainder out; and S4: mixing two decoctions; pulverizing the Hirudo; mixing the decoction with Hirudo powder before taking.
2. The Coptis Chinensis and Atractlodis Rhizoma based prescription for treating diabetes of claim 1, wherein the prescription is prepared with the following raw materials of traditional Chinese medicine: Coptis Chinensis 30g, stir-fried Atractlodis Rhizoma 12g, stir-fried Fructus Aurantii Immaturus 10g, Skunk Bugbane Rhizome 10g, ginger processed Ternate Pinellia 10g, Tangerine Peel 12g, Poria Cocos 15g, Rhizoma Alismatis 30g, stir-fried Medicated Leaven 10g, stir-fried Chinese Hawthorn Fruit 30g, Hirudo 3g, Stiff Silkworm 10g, Dried Ginger 10g, Fructus Ziziphi Jujubae 10g and Liquorice Root 6g.
3. The Coptis Chinensis and Atractlodis Rhizoma based prescription for treating diabetes of claim 1, wherein the prescription is prepared with the following raw materials of traditional Chinese medicine: Coptis Chinensis 10g, stir-fried Atractlodis Rhizoma 8g, stir-fried Fructus Aurantii Immaturus 7g, Skunk Bugbane Rhizome 6g, ginger processed Ternate Pinellia 7g, Tangerine Peel 8g, Poria Cocos 10g, Rhizoma Alismatis 20g, stir-fried Medicated Leaven 7g, stir-fried Chinese Hawthorn Fruit 20g, 40 Hirudo 2g, Stiff Silkworm 7g, Dried Ginger 7g, Fructus Ziziphi Jujubae 7g and Liquorice Root 4g.
4. The Coptis Chinensis and Atractlodis Rhizoma based prescription for treating diabetes of claim 1, wherein the prescription is prepared with the following raw materials of traditional Chinese medicine: Coptis Chinensis 40g, stir-fried Atractlodis
BL-5396 9 Rhizoma 16g, stir-fried Fructus Aurantii Immaturus 13g, Skunk Bugbane Rhizome 13g, LU501408 ginger processed Ternate Pinellia 13g, Tangerine Peel 16g, Poria Cocos 20g, Rhizoma Alismatis 40g, stir-fried Medicated Leaven 13g, stir-fried Chinese Hawthorn Fruit 40g, Hirudo 4g, Stiff Silkworm 13g, Dried Ginger 13g, Fructus Ziziphi Jujubae 13g and Liquorice Root 8g.
LU501408A 2022-02-08 2022-02-08 A coptis chinensis and atractlodis rhizoma based prescription for treating diabetes LU501408B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
LU501408A LU501408B1 (en) 2022-02-08 2022-02-08 A coptis chinensis and atractlodis rhizoma based prescription for treating diabetes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU501408A LU501408B1 (en) 2022-02-08 2022-02-08 A coptis chinensis and atractlodis rhizoma based prescription for treating diabetes

Publications (1)

Publication Number Publication Date
LU501408B1 true LU501408B1 (en) 2022-08-11

Family

ID=82848755

Family Applications (1)

Application Number Title Priority Date Filing Date
LU501408A LU501408B1 (en) 2022-02-08 2022-02-08 A coptis chinensis and atractlodis rhizoma based prescription for treating diabetes

Country Status (1)

Country Link
LU (1) LU501408B1 (en)

Similar Documents

Publication Publication Date Title
CN104740439A (en) Medicated diet powder with functions of reducing blood glucose and fat, losing weight, recovering pancreas islet functions and controlling diabetic complications
CN103041360B (en) Oral liquid for treating functional diarrhea and irritable bowel syndrome
WO2022021639A1 (en) Traditional chinese medicine composition for invigorating spleen and activating yang, and use thereof
CN101125177B (en) Fermented glutinous wine for treating diabetes
CN105250813A (en) Chinese herb composition for treating jaundice
CN105079494A (en) Dendrobium officinale capsule for lowering blood sugar and preparation method of dendrobium officinale capsule
CN102430105B (en) Traditional Chinese medicine composite for treating chronic gastritis
CN109692309B (en) Traditional Chinese medicine for treating non-alcoholic fatty liver disease, eliminating dampness and activating blood
CN107007686A (en) A kind of Chinese medicine preparation for treating diabetic nephropathy and its preparation, instructions of taking
CN101530565B (en) Chinese traditional medicine preparation used for curing diabetes and preparation method thereof
LU501408B1 (en) A coptis chinensis and atractlodis rhizoma based prescription for treating diabetes
CN109498731A (en) A kind of tonifying speen and tonifying kidney tune sugar-pill and preparation method thereof for treating diabetes B Pishenqixu syndrome
CN103055176B (en) Traditional Chinese medicine for treating diabetes mellitus and preparation method thereof
CN104667249B (en) A kind of Chinese medicine composition for treating primary dysmenorrhea
CN101095881B (en) Decoction medicine for treating indigestion type biliary ascariasis and preparation method thereof
CN105663772B (en) A kind of drug for treating diabetes
CN102552743A (en) Medicinal composition for treating diabetes and preparation method thereof
CN102114185B (en) Medicament for treating insulin resistance of type 2 diabetes
CN105233147A (en) Preparation method of traditional Chinese medicine preparation for treating gout
CN101884760B (en) Chinese medicinal composition for treating diabetes mellitus and preparation method thereof
CN101085330A (en) Oral administration traditional Chinese medicine composition for treating hyperlipoidemia
CN110680861A (en) A Chinese medicinal composition for treating diabetes
CN107854588A (en) A kind of Chinese medicine composition for treating fatty liver and preparation method thereof
CN102366480A (en) Medicine for treating diabetes and preparation method thereof
CN101468071B (en) Chinese medicine medicine for suppressing and alleviating sex urge for male and female

Legal Events

Date Code Title Description
FG Patent granted

Effective date: 20220811